A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease
Clinical trial NCT00035204 · COMPLETED
Trial details
- NCT number
- NCT00035204
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.